GlassScriptPhysician profile
David Alan Ginsberg
NPI 1073534525
$22,679.25
in general payments reported to CMS, 2019-2025
22 companies · $1,399 in 2025
The $1,399 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,683 · 2020: $577 · 2021: $2,431 · 2022: $14K · 2023: $1,388 · 2024: $1,393 · 2025: $1,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,180.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $6,750.00 | 2022 | |
| Medtronic, INC. | $6,650.39 | 2021-2025 | Interstim, Ligasure, Signia |
| Laborie Medical Technologies Corp. | $3,500.00 | 2022 | |
| Medtronic USA, INC. | $1,481.68 | 2019-2020 | |
| Boston Scientific Corporation | $1,192.95 | 2019-2025 | Advantage System, Solyx Sis System, General - Female Sui |
| Axonics, INC. | $628.65 | 2021-2024 | Axonics, Bulkamid |
| Abbvie INC. | $552.58 | 2022-2025 | |
| Coloplast Corp | $431.55 | 2024-2025 | |
| Bluewind Medical | $344.57 | 2024-2025 | Revi |
| Allergan, INC. | $292.15 | 2019-2020 | |
| Janssen Biotech, INC. | $257.62 | 2023-2025 | Carvykti, Rybrevant, Tremfya |
| Urovant Sciences INC | $150.13 | 2022 | |
| Karl Storz Endoscopy-America | $132.65 | 2019 | |
| Organon LLC | $96.77 | 2021-2023 | Nexplanon |
| Astellas Pharma US INC | $78.43 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $27.77 | 2022 | |
| Sumitomo Pharma America, INC. | $25.00 | 2023 | Gemtesa |
| Hollister Incorporated | $19.81 | 2023 | Vapro Plus Pocket |
| Sagent Pharmaceuticals | $18.41 | 2020 | |
| Biogen, INC. | $18.19 | 2021 | |
| Merck Sharp & Dohme LLC | $15.31 | 2020 | |
| Urogen Pharma, INC. | $14.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ginsberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.